Questions For Our Attorneys?
We stand for our clients.Call us today: (855) 264-6270

Topics

PAST ARTICLES

By | November 22, 2016

FDA Mandates Boxed Warning, Patient Checklist for Essure

The U.S. Food and Drug Administration (FDA) recommended on Nov. 15 a boxed warning and a patient checklist that highlights possible adverse events associated with the use of Essure, Bayer’s permanent contraception… Read More

By | March 24, 2016

In the News: ‘Eye-popping’ $502 Million Verdict Holds Johnson & Johnson, DePuy Accountable for Defective Hip Implants

A Texas jury awarded a $502 million verdict last Thursday to five plaintiffs injured by Pinnacle hip implant devices. The verdict, called ‘eye-popping’ by Law360, holds Johnson & Johnson (J&J) and DePuy… Read More

By | October 26, 2015

The History of Risperdal in the Pharmaceutical Marketplace

Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders in adults. Its manufacturer, Johnson & Johnson (J&J), has recently been making… Read More

By | February 5, 2014

Simmons Hanly Conroy Files First Testosterone Treatment Lawsuits, Bloomberg Reports

Yesterday, attorneys at the firm filed the first testosterone treatment lawsuit on behalf of five men against Abbott Laboratoes and AbbVie, Inc. The men range in age from 50 to 63 and… Read More

By | June 7, 2013

DA Approves Liptruzet – Merck’s Combination of Zetia and Lipitor

The Food and Drug Administration recently approved a new cholesterol-lowering medication called Liptruzet. This drug combines two already existing medications. The first, Zetia, goes by the generic name ezetimibe and works by… Read More

By | December 23, 2010

Looking Back, Moving Forward

For me, December and the holiday season has always been a time to reflect on the past year. A time to remember the challenges we’ve overcome; the projects we’ve spearheaded; and the… Read More